<div id="readability-page-1"><p>Mativ (NYSE:MATV - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.12, FiscalAI reports. The business had revenue of $513.70 million for the quarter, compared to analyst estimates of $505.00 million. Mativ had a negative net margin of 23.09% and a positive return on equity of 4.12%.</p><h2>Mativ Stock Up 2.6%</h2><ul><li>3 High-Yield Dividend Stocks Trading at a Discount</li></ul><p>Mativ stock traded up $0.27 during trading hours on Wednesday, hitting $10.55. The stock had a trading volume of 424,842 shares, compared to its average volume of 714,245. The company has a quick ratio of 1.21, a current ratio of 2.37 and a debt-to-equity ratio of 2.65. The stock has a market capitalization of $576.91 million, a P/E ratio of -1.26 and a beta of 0.86. Mativ has a 12-month low of $4.34 and a 12-month high of $17.47. The stock's 50-day moving average price is $11.44 and its 200-day moving average price is $8.67. </p><h2>Institutional Trading of Mativ</h2><p>Large investors have recently made changes to their positions in the stock. Osaic Holdings Inc. grew its stake in shares of  Mativ by 939.9% in the second quarter. Osaic Holdings Inc. now owns 11,668 shares of the company's stock worth $80,000 after acquiring an additional 10,546 shares during the period.  Envestnet Asset Management Inc. bought a new stake in shares of  Mativ in the third quarter worth approximately $144,000.  The Manufacturers Life Insurance Company grew its stake in shares of  Mativ by 5.0% in the second quarter. The Manufacturers Life Insurance Company now owns 20,608 shares of the company's stock worth $141,000 after acquiring an additional 976 shares during the period.  Oxford Asset Management LLP bought a new stake in shares of  Mativ in the second quarter worth approximately $145,000.  Finally, Creative Planning bought a new stake in shares of  Mativ in the second quarter worth approximately $159,000. 94.95% of the stock is currently owned by institutional investors. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of brokerages have recently weighed in on MATV. Wall Street Zen raised shares of Mativ from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, August 9th. Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of Mativ in a research note on Wednesday, October 8th. Finally, Zacks Research cut shares of Mativ from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, October 7th. One equities research analyst  has rated the stock with a Buy rating, one  has given a Hold rating and one  has assigned  a Sell rating to the company. According to data from MarketBeat, the company  has a consensus rating of &#34;Hold&#34; and a consensus target price of $10.00.</p><p><b>Get Our Latest Analysis on Mativ</b></p><h2>Mativ Company Profile</h2> (Get Free Report)<p>Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.</p><h2>Read More</h2><ul><li>Five stocks we like better than Mativ</li><li>3 Warren Buffett Stocks to Buy Now</li><li>3 Cash-Rich Stocks With High Growth Potential Right Now</li><li>When to Sell a Stock for Profit or Loss</li><li>Why Vertical Aerospace Stock Could Double After This Flight Test</li><li>How to Capture the Benefits of Dividend Increases</li><li>Amazon: Breakout Confirmed—Here’s Where It Could Go Next</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1BVFY?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1BVFY"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Mativ Right Now?</h2><p>Before you consider Mativ, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.</p><p>While Mativ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MATV

<p>Mativ (NYSE:MATV) reported earnings of $0.39 per share for the quarter, exceeding estimates of $0.27. The company generated revenue of $513.70 million, surpassing the expected $505.00 million. Mativ has a negative net margin of 23.09% and a positive return on equity of 4.12%. The stock rose 2.6% to $10.55, with institutional investors holding 94.95% of shares. Analysts have mixed ratings, with a consensus rating of "Hold" and a target price of $10.00.</p>

Mativ (NYSE:MATV) Issues Earnings Results